RAPID DETERMINATION OF CARBOPLATIN AND DOCETAXEL USİNG RP-HPLC WİTH PDA DETECTOR

Authors

  • POTTURI RAMA DEVI Department of Chemistry, RVR & JC College of Engineering, Guntur 522019, A. P., India
  • KANTIPUDI RAMBABU Department of Chemistry, RVR & JC College of Engineering, Guntur 522019, A. P., India

DOI:

https://doi.org/10.22159/ijap.2022v14i2.43633

Keywords:

Carboplatin, Docetaxel, RP-HPLC, Development, Validation

Abstract

Objective: In the current investigation, to separated and validate the cancer healing drugs (Carboplatin and Docetaxel) through the HPLC (e-2695) instrument containing a PDA detector.

Methods: A simple, selective, validated and well-defined stability that shows isocratic RP-HPLC methodology for the quantitative determination of Carboplatin and Docetaxel. The chromatographic strategy utilized Symmetry C18 column of dimensions 150x4.6 mm, 3.5 micron, using isocratic elution with a mobile phase of acetonitrile and 0.1% ortho phosphoric acid (40:60). A flow rate of 1 ml/min and a detector wavelength of 225 nm utilizing the PDA detector were given in the instrumental settings. Recovery, specificity, linearity, accuracy, robustness, ruggedness were determined as a part of method validation and the results were found to be within the acceptable range. Validation of the proposed method was carried out according to an international conference on harmonization (ICH) guidelines.

Results: LOD and LOQ for the two active ingredients were established with respect to test concentration. The calibration charts plotted were linear with a regression coefficient of R2 > 0.999.

Conclusion: The proposed method to be fast, simple, feasible and affordable in assay condition. During stability tests, it can be used for routine analysis of production samples and to verify the quality of drug samples during stability studies.

Downloads

Download data is not yet available.

References

Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D, et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell International 2015; 15: 71.

Felici A, Verweij J, Sparreboom A. Dosing strategies for anticancer drugs: the good, the bad and body-surface area. Eur J Cancer 2002; 38: 1677–84.

Qato DM, Wilder J, Schumm L, Gillet V, Alexander G. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011. JAMA Intern Med 2016; 176: 473–82.

Ebell MH, Culp MB, Radke TJ. A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer. Am J Prev Med 2016; 50: 384–94.

Williams C, Simera I, Bryant A. Tamoxifen for relapse of ovarian cancer. Cochrane Database Syst Rev 2010; 2020: CD001034.

Oguri S, Sakakibara T, Mase H, Shimizu T, et al. Clinical pharmacokinetics of carboplatin. J Clin Pharmacol 1988; 28: 208-15.

Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, et al. Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 1982; 9: 140-7.

Ramesh Deepthi, Vijayakumar Balaji Gowrivel, Kannan Tharanikkarasu. Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections. Chem Med Chem 2021; 16: 1403–19.

Zaharevitz DW, Anderson LW, Malinowski NM, Hyman R, Strong JM, Cysyk RL. Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivo. Eur J Biochem 1992; 210: 293–6.

Belloc S, Benkhalifa M, Cohen-Bacrie M, Dalleac A, Chahine H, et al. Which isolated sperm abnormality is most related to sperm DNA damage in men presenting for infertility evaluation. J Assist Reprod Genet 2014; 31: 527–32.

Speyer BE, Pizzey AR, Ranieri M, Joshi R, Delhanty JD, Serhal P. Fall in implantation rates following ICSI with sperm with high DNA fragmentation. Hum Reprod 2010; 25: 1609–18.

Adkins JN, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002; 1: 947–55.

Kumar EP, Kumar AnilD, Parasuraman S, Rajan VijayR, Emerson SF. Hepatoprotective activity of Clearliv a polyherbal formulation in Wistar rats. Archives of Medicine and Health Sciences 2013; 1: 120–5.

Wallace JL. Acetaminophen hepatotoxicity: NO to the rescue. Br J Pharmacol 2004; 143: 1–2.

Donadieu J, Beaupain B, Fenneteau O, Bellanné-Chantelot C. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. Br J Haematol 2017; 179: 557–74.

Horwitz MS, Corey SJ, Grimes HL, Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am 2013; 27: 19–41, vii.

Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 2011; 47: 33–43.

Jassim GA, Whitford DL, Hickey A, Carter B. Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev 2015; CD008729.

Aupérin Anne. Epidemiology of head and neck cancers: an update. Curr Opin Oncol 2020; 32: 178–86.

Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am 2014; 26: 123–41.

Heise K, Bertran E, Andia ME, Ferreccio C. Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol 2009; 15: 1854–62.

Bello JO. Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer. BMC Urol 2017; 17: 39.

Catalona WJ. Prostate Cancer Screening. The Medical Clinics of North America 2018; 102 (2): 199–214.

Simon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 324S–39S.

Sherwood J, Dearden S, Ratcliffe M, Walker J. Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review. J Exp Clin Cancer Res 2015; 34: 92.

Wills CP, Young M, White DW. Pitfalls in the evaluation of shortness of breath. Emerg Med Clin North Am 2010; 28: 163–81, ix.

Snyder J G, Ambegaonkar J P, Winchester J B, McBride J M, Andre M J, Nelson A G. Efficacy of Cold-Water Immersion in Treating Delayed Onset Muscle Soreness in Male Distance Runners. Medicine & Science in Sports & Exercise 2011; 43: 766.

Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007; 10: 464–73.

Tripodi Armando, Mannucci Pier Mannuccio. The Coagulopathy of Chronic Liver Disease. N Engl J Med 2011; 365: 147–56.

Kapoor V, Hirst WG, Hentschel C, Preibisch S, Reber S. MTrack: Automated Detection, Tracking, and Analysis of Dynamic Microtubules. Scientific Reports 2019; 9: 3794.

Ganguly A, Yang H, Sharma R, Patel KD, Cabral F. The role of microtubules and their dynamics in cell migration. J Biol Chem 2012; 287: 43359–69.

Subrahmanyam Talari, Anuradha V, Komala sai prathyusha A. New Validated RP-HPLC Method for Cisplatin and Topotecan in API and Vaccine Form and its Stress Studies. Int J Res Pharm Sci 2021; 12: 808-14.

Syed Rafi, Kantipudi Rambabu. Stability indicating validated HPLC method for the determination of Aceclofenac and Misoprostol in bulk and Pharmaceutical formulation. Int J Res Pharm Sci 2020; 11: 7848-53.

Bhavani P, Prasada Rao K, Mohan S. Novel validated reversed phase high performance liquid chromatography method for determination of glucosamine, diacerein, and methyl sulfonyl methane in micro sample rat plasma and its application to pharmacokinetic and dissolution studies. Asian J Pharm Clin Res 2020; 13: 50-63.

Shivani C P, Maheshwari D G. Development and validation of UV spectrometric and HPLC method for estimation of escitalopram oxalate and flupentixol dihydrochloride in combined dosage form. AJPTI 2016; 4: 59-70.

Naresh Kumar D. S, Patel D. Stability indicating chromatographic method development and validation for the simultaneous estimation of escitalopram oxalate and flupentixol in its pharmaceutical dosage form by HPLC. WJPR 2017; 6:549-66.

Supriya T, Naresh D, Vijaya Kumar G, Haneer MA. Stability indicating RP-HPLC method development and validation for simultaneous estimation of escitalopram and flupentixol pure and marketed formulation. Asian J Pharm Res 2018; 8:4-10.

Malathi S, Devakumar D. Development and validation of rp-hplc method for the estimation of escitalopram oxalate and flupentixol dihydrochloride in combined dosage form and plasma. Int J Pharm Pharm Sci 2021; 13: 61-66.

Mukta D. Naykode, Durgacharan A. Bhagwat, Swapnil D. Jadhav, Harinath N, et al. Analytical and bio analytical method for quantification of pure azilsartan, not its salt by RP-HPLC. Research J. Pharm. and Tech 2017; 10:708-14.

Mayanka Singh, Manoj Charde, Rajesh Shukla, Rita M.C. Determination of calcipotriene in calcipotriene cream 0.05% w/w by RP-HPLC method development and validation. Research J. Pharm. and Tech 2011; 4: 1219-23.

Asha Eluru, Surendra Babu K. A Study of Method Development, Validation and Forced Degradation for Simultaneous Quantification of Povidone Iodine and Ornidazole in Bulk and Pharmaceutical Dosage Form by Using RP-HPLC. IJPSR 2021; 12: 1217-22.

Senthil Rajan D, Muruganathan G, Shivkumar K, Ganesh T. Development and validation of hplc method for simultaneous quantification of vasicine, glycyrrhizin and piperine in poly herbal cough syrup. Int J Curr Pharm Res 2020; 12: 15-19.

Malak Y, Al-Bathish A. A, Gazy M. K. El-Jamal. Rp-hplc and chemometric methods for the determination of two anti-diabetic mixtures;metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci 2020; 12: 83-94.

Gadhvi M.P, Bhandari A, Suhagia B.N, Desai U.H. Development and validation of RP-HPLC method for simultaneous estimation of atazanavir and ritonavir in their combined tablet dosage form. Research J. Pharm. and Tech 2013; 6:200-203.

Swati K, Abhishek P, Sushank S, Bothiraja C, Atmaram P. High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring. Int J Pharm Pharm Sci 2020; 12: 92-7.

Gomathy S, Narenderan S.T, Meyyanathan S.N, Gowramma B. Development and validation of hplc method for the simultaneous estimation of apigenin and luteolin in commercial formulation. J. Crit. Rev 2020; 7: 4785-90.

Vijayakumari M, Balasekhar reddy Ch. Stability indicating validated hplc method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res 13: 2020; 159-62.

Abdul Raziq, Syed Umer Jan et al., Relative comparison of stability and degradation of methylcobalamine tablets of different brands at different storage settings. Int J App Pharm 2021; 13:171-5.

Rajakumari R, Sreenivasa Rao S et.al., Stress degradation studies and development of a validated RP-HPLC method for determination of Tiagabine in presence of its degradation products. Int J Pharm Pharm Sci 2016; 8: 230-6.

Charu Pandya P, Sadhana Rajput J. Development and validation of stability indicating method RP-HPLC method of Acotiamide. Int J Pharm Pharm Sci 2018; 10: 1-8.

Birva Athavia A, Zarna Dedania R et.al., Stability indicating HPLC method for determination of Vilazodone hydrochloride. Int J Curr Pharm Res 2017; 9: 123-9.

Published

06-01-2022

How to Cite

DEVI, P. R., & RAMBABU, K. (2022). RAPID DETERMINATION OF CARBOPLATIN AND DOCETAXEL USİNG RP-HPLC WİTH PDA DETECTOR. International Journal of Applied Pharmaceutics, 14(2). https://doi.org/10.22159/ijap.2022v14i2.43633

Issue

Section

Original Article(s)